Analyst Research

Report Title Price
Provider: Stock Traders Daily
$20.00
Provider: Stock Traders Daily
$20.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: New Constructs, LLC
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Amgen Inc Names Robert A. Bradway Chairman Of Board Of Directors


Thursday, 13 Dec 2012 07:46pm EST 

Amgen Inc announced appointments to its Board of Directors. Robert A. Bradway, Chief Executive Officer, has been appointed Chairman of the Board, and Vance D. Coffman, an Amgen Director since 2007, has been appointed lead independent director, both effective on January 1, 2013. As previously announced, Kevin W. Sharer is retiring from the Board, effective December 31, 2012. 

Company Quote

119.77
0.82 +0.69%
11 Jul 2014